Envisagenics

Envisagenics is an AI-driven biotechnology company focused on discovering and developing novel RNA splicing therapeutics. They utilize their cloud-based AI drug discovery platform, SpliceCore, to identify disease-specific targets for immunotherapies and RNA therapeutics. The company collaborates with biopharmaceutical companies and academic institutions.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount:

Date: 05-Jun-2024

Investors: Third Kind Venture Capital, Empire State Development, Red Cell Partners, Bristol Myers Squibb

Markets: Biotechnology, AI, Drug Discovery, Oncology, RNA Therapeutics

HQ: Long Island City, New York, United States

Founded: 2014

Website: https://www.envisagenics.com

LinkedIn: https://www.linkedin.com/company/envisagenics

Twitter: https://twitter.com/envisagenics

Instagram: